Prediction of quality of life in schizophrenia using machine learning models on data from clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia

被引：0
|
作者：
Beaudoin, M. [1 ,2 ,3 ]
Potvin, S. [1 ,2 ]
Hudon, A. [1 ,2 ]
Giguere, C. -E. [2 ]
Dumais, A. [1 ,2 ,4 ]
机构：
[1] Univ Montreal, Psychiat & Addictol, Montreal, PQ, Canada
[2] Inst Univ Sante Mentale Montreal, Ctr Rech, Montreal, PQ, Canada
[3] McGill Univ, Fac Med, Montreal, PQ, Canada
[4] Inst Natl Psychiat Iegale Philippe Pinel, Psychiat, Montreal, PQ, Canada
来源：
EUROPEAN PSYCHIATRY | 2021年 / 64卷
关键词：
schizophrenia; quality of life; machine learning; predictive models;
D O I：
10.1192/j.eurpsy.2021.423
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
O249
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [1] Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial
    Mélissa Beaudoin
    Alexandre Hudon
    Charles-Edouard Giguère
    Stéphane Potvin
    Alexandre Dumais
    [J]. Schizophrenia, 8
  • [2] Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial
    Beaudoin, Melissa
    Hudon, Alexandre
    Giguere, Charles-Edouard
    Potvin, Stephane
    Dumais, Alexandre
    [J]. SCHIZOPHRENIA, 2022, 8 (01)
  • [3] Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
    Volavka, Jan
    Czobor, Pal
    Citrome, Leslie
    Van Dorn, Richard A.
    [J]. CNS SPECTRUMS, 2014, 19 (05) : 374 - 381
  • [4] Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial
    Swartz, MS
    Perkins, DO
    Stroup, TS
    McEvoy, JP
    Nieri, JM
    Haak, DC
    [J]. SCHIZOPHRENIA BULLETIN, 2003, 29 (01) : 33 - 43
  • [5] Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Primary efficacy and safety outcomes of the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial
    Lieberman, JA
    Stroup, TS
    McEvoy, JP
    Swartz, MS
    Rosenheck, RA
    Perkins, DO
    Keefe, RS
    Davis, SM
    Davis, CE
    Lebowitz, B
    Hsiao, J
    Severe, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S32 - S32
  • [6] Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study
    Stroup, TS
    Appelbaum, PS
    [J]. SCHIZOPHRENIA BULLETIN, 2006, 32 (01) : 147 - 152
  • [7] Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    Citrome, L.
    Stroup, T. Scott
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) : 933 - 940
  • [8] Life Satisfaction Among Individuals With Schizophrenia in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) Study
    Fervaha, Gagan
    Agid, Ofer
    Takeuchi, Hiroyoshi
    Foussias, George
    Remington, Gary
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (09): : 1061 - 1062
  • [9] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Palmer, B
    Harvey, PD
    Davis, S
    McEvoy, J
    Golberg, T
    Gold, J
    Green, MF
    Swartz, MS
    Stroup, S
    Rosenheck, R
    Perkins, D
    Meltzer, H
    Lieberman, JA
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 79S - 79S
  • [10] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Harvey, PD
    Davis, S
    Palmer, B
    McEvoy, JP
    Goldberg, TE
    Gold, JM
    Green, MR
    Swartz, M
    Stroup, S
    Rosenheck, R
    Perkins, DO
    Meltzer, HY
    Miller, D
    Canive, J
    Walker, TM
    Lieberman, JA
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 361 - 362
12345